These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11502857)

  • 81. Detection of serum anti-melanocyte antibodies and identification of related antigens in patients with vitiligo.
    Zhu MC; Liu CG; Wang DX; Zhan Z
    Genet Mol Res; 2015 Dec; 14(4):16060-73. PubMed ID: 26662399
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Vitiligo--part 1.
    Tarlé RG; Nascimento LM; Mira MT; Castro CC
    An Bras Dermatol; 2014; 89(3):461-70. PubMed ID: 24937821
    [TBL] [Abstract][Full Text] [Related]  

  • 83. ΜicroRNA‑421 participates in vitiligo development through regulating human melanocyte survival by targeting receptor‑interacting serine/threonine kinase 1.
    Sun X; Wang T; Huang B; Ruan G; Xu A
    Mol Med Rep; 2020 Feb; 21(2):858-866. PubMed ID: 31974624
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin.
    Le Poole IC; Stennett LS; Bonish BK; Dee L; Robinson JK; Hernandez C; Hann SK; Nickoloff BJ
    Br J Dermatol; 2003 Oct; 149(4):739-48. PubMed ID: 14616364
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Complement-fixing activity to melanin-producing cells preceding the onset of vitiligo in a patient with type 1 polyglandular failure.
    Betterle C; Caretto A; Pedini B; Rigon F; Bertoli P; Peserico A
    Arch Dermatol; 1992 Jan; 128(1):123-4. PubMed ID: 1739282
    [No Abstract]   [Full Text] [Related]  

  • 86. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
    van Geel NA; Mollet IG; De Schepper S; Tjin EP; Vermaelen K; Clark RA; Kupper TS; Luiten RM; Lambert J
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):375-84. PubMed ID: 20370855
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Fas-FasL interaction in cytotoxic T cell-mediated vitiligo: The role of lesional expression of tumor necrosis factor-α and interferon-γ in Fas-mediated melanocyte apoptosis.
    Jimbo H; Nagai H; Fujiwara S; Shimoura N; Nishigori C
    Exp Dermatol; 2020 Jan; 29(1):61-70. PubMed ID: 31675451
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression.
    Rezk AF; Kemp DM; El-Domyati M; El-Din WH; Lee JB; Uitto J; Igoucheva O; Alexeev V
    J Invest Dermatol; 2017 May; 137(5):1126-1134. PubMed ID: 28132854
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Antigen Specificity Enhances Disease Control by Tregs in Vitiligo.
    Mukhatayev Z; Dellacecca ER; Cosgrove C; Shivde R; Jaishankar D; Pontarolo-Maag K; Eby JM; Henning SW; Ostapchuk YO; Cedercreutz K; Issanov A; Mehrotra S; Overbeck A; Junghans RP; Leventhal JR; Le Poole IC
    Front Immunol; 2020; 11():581433. PubMed ID: 33335528
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evaluation of serum immunoglobulins concentrations and distributions in vitiligo patients.
    Li Y; Yang M; Zhang R; Liu W; Zhang K; Wen W; Yi L; Wang Q; Hao M; Yang H; Chang J; Li J
    Immunol Res; 2016 Dec; 64(5-6):1150-1156. PubMed ID: 27417998
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis.
    Raam L; Kaleviste E; Šunina M; Vaher H; Saare M; Prans E; Pihlap M; Abram K; Karelson M; Peterson P; Rebane A; Kisand K; Kingo K
    Front Immunol; 2018; 9():2707. PubMed ID: 30515176
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The detection of melanocyte autoantibodies in the Smyth chicken model for vitiligo.
    Austin LM; Boissy RE; Jacobson BS; Smyth JR
    Clin Immunol Immunopathol; 1992 Aug; 64(2):112-20. PubMed ID: 1643744
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo.
    Shi Q; Zhang W; Guo S; Jian Z; Li S; Li K; Ge R; Dai W; Wang G; Gao T; Li C
    Cell Death Differ; 2016 Mar; 23(3):496-508. PubMed ID: 26315342
    [TBL] [Abstract][Full Text] [Related]  

  • 94. RIP1-Mediated Necroptosis Facilitates Oxidative Stress‒Induced Melanocyte Death, Offering Insight into Vitiligo.
    Li B; Yi X; Zhuang T; Zhang S; Li S; Yang Y; Cui T; Chen J; Chang Y; Gao T; Li C; Liu L
    J Invest Dermatol; 2021 Dec; 141(12):2921-2931.e6. PubMed ID: 34102211
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Congenital stable symmetrical type vitiligo in a patient whose mother developed vitiligo during pregnancy.
    Kedward AL; Gawkrodger DJ
    Eur J Dermatol; 2008; 18(3):353. PubMed ID: 18515208
    [No Abstract]   [Full Text] [Related]  

  • 96. Role of apoptosis and melanocytorrhagy: a comparative study of melanocyte adhesion in stable and unstable vitiligo.
    Kumar R; Parsad D; Kanwar AJ
    Br J Dermatol; 2011 Jan; 164(1):187-91. PubMed ID: 21175561
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
    Mosenson JA; Zloza A; Nieland JD; Garrett-Mayer E; Eby JM; Huelsmann EJ; Kumar P; Denman CJ; Lacek AT; Kohlhapp FJ; Alamiri A; Hughes T; Bines SD; Kaufman HL; Overbeck A; Mehrotra S; Hernandez C; Nishimura MI; Guevara-Patino JA; Le Poole IC
    Sci Transl Med; 2013 Feb; 5(174):174ra28. PubMed ID: 23447019
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.
    Birlea SA; Costin GE; Roop DR; Norris DA
    Med Res Rev; 2017 Jul; 37(4):907-935. PubMed ID: 28029168
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
    Palermo B; Campanelli R; Garbelli S; Mantovani S; Lantelme E; Brazzelli V; Ardigó M; Borroni G; Martinetti M; Badulli C; Necker A; Giachino C
    J Invest Dermatol; 2001 Aug; 117(2):326-32. PubMed ID: 11511311
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.